Swich CV 325 Tablet

Swich CV 325 Tablet is a combination antibiotic that contains Cefpodoxime Proxetil and Clavulanic Acid. It is mainly prescribed for respiratory tract infections, including those affecting the throat, sinuses, airways, and lungs. This medicine works by treating the infection and preventing harmful bacteria from multiplying further.

It should be taken exactly as advised by your doctor and preferably at the same time each day for maximum benefit. It can be taken with or without food, but the dose should not be exceeded. Even if you start feeling better after a few doses, the full course of treatment must be completed to ensure that the infection is fully cleared and does not come back. If you miss a dose, take it as soon as you remember, unless it is almost time for your next scheduled dose. In that case, skip the missed dose and continue with the regular routine. Do not take two doses at once.

Some people may experience side effects such as nausea, vomiting, diarrhea, stomach discomfort, headache, rash, or in some cases, vaginal infection. These effects are usually mild and disappear as the body adjusts to the medicine. If they persist or worsen, or if you notice signs of an allergic reaction such as swelling, rash, itching, or breathing problems, seek medical help immediately.

Before starting Swich CV 325 Tablet, inform your doctor about any ongoing medications or health conditions, particularly if you have kidney or liver disease. Pregnant or breastfeeding women should only use this medicine after consulting their doctor. Alcohol should be avoided during treatment as it may increase drowsiness or interact with the medicine. The medicine may sometimes cause dizziness, allergic reactions, or seizures, which can make it unsafe to drive.

Swich CV 325 Tablet works by combining two different actions. Cefpodoxime Proxetil is an antibiotic that kills bacteria by preventing the formation of their protective cell wall, while Clavulanic Acid is a beta-lactamase inhibitor that prevents bacteria from becoming resistant and enhances the effect of Cefpodoxime Proxetil. Together, they provide stronger protection against infection.

In patients with severe kidney problems, dose adjustments may be necessary. For those with liver conditions, data on its use is limited, so medical advice is essential before starting treatment.